PUNE, India, September 10, 2015 /PRNewswire/ --
The Microbiology Testing / Clinical Microbiology Market by Product, Clinical Application and by Industry - Global Forecast to 2019 research report estimates this industry to reach $12,411.36 Million in 2019 at a CAGR of 13.03% between 2014 and 2019.
Complete report on clinical microbiology market spread across 200 pages, profiling 11 companies and supported with 81 tables and 121 figures is now available at http://www.rnrmarketresearch.com/microbiology-testingclinical-microbiology-market-by-product-instrument-analyzer-incubator-kit-microscope-molecular-diagnostics-clinical-application-periodontal-disease-respiratory-diseases-market-report.html .
The pharmaceuticals application segment accounted for the largest share of the clinical microbiology market in 2014, while the food application segment is expected grow at the highest CAGR between 2014 and 2019. The clinical microbiology market is segmented on the basis of products into consumables and instruments. Each of these market segments is further divided into multiple product segments and sub segments. The clinical microbiology consumables market consists of two sub-segments, namely, kits and reagents. The kits segment accounted for the largest share of the clinical microbiology consumables market in 2014 and is expected to grow at the highest CAGR between 2014 and 2019. The laboratory instruments accounted for the largest share of the clinical microbiology instruments market in 2014, whereas the automated microbiology instruments segment is expected to grow at the highest CAGR between 2014 and 2019. Application wise, the respiratory diseases segment accounted for the largest share of the clinical microbiology market in 2014, and is expected to grow at the highest CAGR between 2014 and 2019.
Clinical microbiology has applications in a large number of infectious diseases. On the basis of applications, the report is segmented into blood stream infections, gastrointestinal diseases, periodontal diseases, respiratory diseases, sexually transmitted diseases, urinary tract infections, and other diseases. The geographic segments included in this clinical microbiology market report are Asia, Europe, North America, and Rest of the World. The large disease burden of infectious diseases is the key growth driver for this market. The outbreak of new diseases has further aided the growth of this market. The growing trend of laboratory automation and the increase in access to medical insurance in the U.S. market will aid the growth of clinical microbiology market. Moreover, increased healthcare expenditure will drive the growth of this market.
Companies profiled in this 2015 clinical microbiology market research include Becton, Dickinson and Company, Biomérieux SA, Cepheid, Danaher Corporation, Siemens AG, Abbott Laboratories, Inc., Alere, Inc., Bio-Rad Laboratories, Inc., Bruker Corporation, F. Hoffmann-LA Roche Ltd. and Hologic, Inc. Order a copy of Microbiology Testing / Clinical Microbiology Market by Product (Instrument, Analyzer, Incubator, Kit, Microscope, Molecular Diagnostics), Clinical Application (Periodontal Disease, Respiratory Diseases, STD, UTI) & by Industry - Global Forecast to 2019 research report at http://www.rnrmarketresearch.com/contacts/purchase?rname=259270 .
For decision makers and stakeholders of molecular biology market, RnRMarketResearch.com has other newly published a well as relevant research titles that may be of interest:
Bioburden Testing Market by Product [Instrument (PCR, Microscopes), & Consumables (Kit, Reagent)], Test (Aerobic, Anaerobic, Fungi, Spore), Application (Raw Material, In-process) & End User (Pharmaceutical, Biotechnology, CMO) - Forecast to 2019: The bioburden testing market is expected to reach $565.6 million by 2019 from $354.4 million in 2014, at a CAGR of 9.8% from 2014 to 2019. The CMOs segment is expected to grow at the highest CAGR in the coming five years. Growth in this segment will be driven by the rising demand for cost-effective alternatives for manufacturing in emerging as well as developed countries. The major factors contributing to the growth of the global bioburden testing market include the growing medical device industry, changing trends in the pharmaceutical and biotechnology industries, increasing food safety concerns to boost the microbial identification market, strong trend of R&D investments in life sciences, and increasing product recalls due to microbial contamination. However, high cost of instruments and complex and time-consuming regulatory standards to lengthen the approval process in some countries may hinder the growth of this market. Companies like Charles River Laboratories International, Inc., Sigma-Aldrich Corporation, SGS S.A., WUXI Pharmatech (Cayman), Inc., Merck & Co., Inc., Becton, Dickinson, and Company, North American Science Associates, Inc. (NAMSA), Nelson Laboratories, Inc., Pacific Biolabs and ATS Labs, Inc. are profiled in this research report available at http://www.rnrmarketresearch.com/bioburden-testing-market-by-product-instrument-pcr-microscopes-consumables-kit-reagent-test-aerobic-anaerobic-fungi-spore-application-raw-material-in-process-end-user-pharmaceu-market-report.html .
Explore more reports on the life sciences market at http://www.rnrmarketresearch.com/reports/life-sciences .
RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Connect with Us:
G+ / Google Plus: https://plus.google.com/104156468549256253075/posts
RSS / Feeds: http://www.rnrmarketresearch.com/feed
SOURCE RnR Market Research